Search

Despite the fact that pharmaceuticals are indispensable for human and animal health, they may cause undesired adverse effects. Specifically, environmentally persistent pharmaceutical pollutants (EPPPs) are slowly degradable or nondegradable, presenting a special risk when they enter, persist or disseminate in the environment. Colombia’s Resolution 371, addressing EPPPs, was awarded for regulating waste management from hazardous products.The World Future Council focuses on identifying, developing, highlighting and spreading effective, future-just solutions for current challenges humanity is facing and promote their implementation worldwide

Residues of pharmaceuticals are known to occur widely in the aquatic environment of industrialized countries. Even in developing and emerging countries, information on the occurrence of pharmaceutical residues in the environment has become more readily available in recent years. However, a concise and comprehensive overview of the relevant pharmaceuticals, their concentrations in the environment and their potential effects on human health and ecosystems is still pending. The information on worldwide exposure of pharmaceuticals is increasing and the German Environment Agency